Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 13 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

23%

3 trials in Phase 3/4

Results Transparency

0%

0 of 12 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(40.0%)
Phase 2
1(20.0%)
Phase 3
1(20.0%)
N/A
1(20.0%)
5Total
Phase 4(2)
Phase 2(1)
Phase 3(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT01704534Phase 2Completed

A Proof of Concept Study to Evaluate the Effectiveness of Ustekinumab in Hidradenitis Suppurativa

Role: collaborator

NCT06318936Recruiting

Respiratory Syncytial Virus (RSV) Burden in Older Adults in Primary Care in The Netherlands

Role: collaborator

NCT05318950Not ApplicableCompleted

A nUtrition and Lifestyle Intervention in Patients With Pulmonary Arterial HypertensIon

Role: collaborator

NCT00440479Completed

ADVANCE: An Observational Study To Determine Bortezomib Safety and Effectiveness at First Relapse After Participation In First Line HOVON-49/50 Clinical Studies.

Role: lead

NCT01641094Completed

Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

Role: collaborator

NCT00264108Completed

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

Role: lead

NCT00697658Completed

INVISION - An Observational Study to Explore Effectiveness, Tolerability and Safety of Paliperidone ER in Patients With Schizophrenia

Role: lead

NCT00264095Completed

An Observational Study of Blood Management Techniques in Oncology Surgical Treatment

Role: lead

NCT00440765Completed

VALEO: A Post Authorization Study, Designed to Learn More About the Safety and Effectiveness of the Use of Bortezomib in the Netherlands

Role: lead

NCT00398749Completed

Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)

Role: lead

NCT00216541Phase 4Completed

A Study of the Safety and Effectiveness of Epoetin Alfa on Hemoglobin Levels and Blood Transfusions in Cancer Patients Receiving Chemotherapy

Role: lead

NCT00446576Phase 3Completed

The Effect of Epoetin Alfa on Cardiac Function and Quality of Life in Patients With Early Renal ((Kidney) Disease

Role: lead

NCT00283465Phase 4Completed

A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

Role: lead

All 13 trials loaded